Green Cross HealthNZSE:GXH +1.01%63 Market Cap is NZ$284.8 Mil as of Jul. 09, 2026. GuruFocus rates NZSE:GXH with a GF Score™ of 63/100 and a GF Value™ of NZ$1.08 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 694 Healthcare Providers & Services companies, Green Cross Health ranks better than 56.63% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Green Cross Health's share price for the quarter that ended in Mar. 2026 was NZ$1.2. Green Cross Health's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 143.7 Mil. Therefore, Green Cross Health's market cap for the quarter that ended in Mar. 2026 was NZ$172.5 Mil.
Green Cross Health's quarterly market cap
increased
from Mar. 2025 (NZ$107.7 Mil) to Sep. 2025 (NZ$124.1 Mil) and
increased
from Sep. 2025 (NZ$124.1 Mil) to Mar. 2026 (NZ$172.5 Mil).
Green Cross Health's annual market cap
declined
from Mar. 2024 (NZ$146.3 Mil) to Mar. 2025 (NZ$107.7 Mil) but then
increased
from Mar. 2025 (NZ$107.7 Mil) to Mar. 2026 (NZ$172.5 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Green Cross Health's Enterprise Value for Today is NZ$395.8 Mil.
Green Cross Health (NZSE:GXH) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Green Cross Health Market Cap Related Terms
Green Cross Health Market Cap Historical Data
* Premium members only.
The historical data trend for Green Cross Health's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Green Cross Health Market Cap Competitor Comparison
For the Pharmaceutical Retailers subindustry, Green Cross Health's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Green Cross Health Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Green Cross Health's Market Cap distribution charts can be found below:
* The bar in red indicates where Green Cross Health's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Green Cross Health's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Green Cross Health (NZSE:GXH) has a Market Cap of NZ$284.8 Mil as of Jul. 09, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Green Cross Health and its competitors. According to the industry distribution chart, Green Cross Health ranks #301 out of 694 companies in the Healthcare Providers & Services industry, placing it in the top 43.4%.
Is Green Cross Health's Market Cap too high?
Green Cross Health's current Market Cap is NZ$284.8 Mil. Based on the distribution chart, Green Cross Health ranks #301 out of 694 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Green Cross Health has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Green Cross Health's Market Cap compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Green Cross Health ranks #301 out of 694 companies for Market Cap. This puts Green Cross Health in the upper half of its industry. The industry median Market Cap is 96.58. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 96.58, based on 694 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Green Cross Health and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 96.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Green Cross Health's current Market Cap is NZ$284.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Green Cross Health stock overvalued right now?
Based on GuruFocus' analysis, Green Cross Health (NZSE:GXH) is currently considered Significantly Overvalued. The stock's GF Value™ is NZ$1.08, compared to a current price of NZ$2.00 — trading 85.2% above its estimated fair value. The current Market Cap is NZ$284.8 Mil. Green Cross Health's overall GF Score™ is 63/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Green Cross Health (NZSE:GXH), the current Market Cap is NZ$284.8 Mil as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Green Cross Health (NZSE:GXH) Overvalued in 2026?
Based on GuruFocus' analysis, Green Cross Health stock appears to be overvalued.
The current stock price of NZ$2.00 is trading 85.2% above its estimated GF Value™ of NZ$1.08.
GuruFocus considers Green Cross Health to be Significantly Overvalued.
Key valuation signals for NZSE:GXH:
Market Cap: NZ$284.8 Mil
GF Value™: NZ$1.08 vs. price of NZ$2.00 (85.2% above fair value)
No single metric tells the full story. See the NZSE:GXH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Green Cross Health Ltd is engaged in providing healthcare services in New Zealand. The reportable segments of the group are Pharmacy services and medical services. The majority of the revenue is generated from the Pharmacy services segment. The pharmacy services segment provides retail and dispensary services, and the medical services segment provides GP, nursing, and urgent care services. The majority of its revenue is generated from the pharmacy segment.
63GF Score
Get the complete analysis for NZSE:GXH
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NZSE:GXH has been successfully added to your 
